The Efficacy and Safety of Cobitolimod (Kappaproct®) in Chronic Active Treatment Refractory Ulcerative Colitis Patients

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2011
The purpose of this study is to determine if cobitolimod (former called Kappaproct®) is effective in the treatment of chronic active ulcerative colitis patients not responding to available therapy.
Epistemonikos ID: de380ad7417b3d697b04735d51471afe08fbc6aa
First added on: Mar 23, 2022